Skip to main content
OSCOTECInc. logo

OSCOTECInc. — Investor Relations & Filings

Ticker · 039200 ISIN · KR7039200001 KO Manufacturing
Open in API
Filings indexed 271 across all filing types
Latest filing 2026-04-09 Major Shareholding Noti…
Country KR South Korea
Listing KO 039200

About OSCOTECInc.

https://oscotec.com/

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a ‘주식등의 대량보유상황보고서’ (Large Shareholding Status Report) filed under Korean Capital Markets law, listing detailed tables of share counts, percentages, dates of acquisition/disposition, and the shareholding purpose. This corresponds exactly to a Major Shareholding Notification (Code: MRQ) rather than an earnings release, AGM, or other corporate report.
2026-04-09 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Annual General Meeting results) and provides detailed voting outcomes for each AGM resolution, including approval of financial statements, director elections, and dividend resolutions. It is a post-meeting announcement of voting results rather than the AGM materials themselves, fitting the Declaration of Voting Results category.
2026-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a Korean regulatory report titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고,” detailing the appointment, dismissal, and resignation of outside directors at OSCOTEC, filed with the Financial Services Commission/Korea Exchange. It lists names, dates, and board composition changes, matching an announcement of changes in the company’s board of directors. Therefore, it falls under Board/Management Information.
2026-03-30 Korean
소송등의판결ㆍ결정
Legal Proceedings Report Classification · 1% confidence The document is a formal regulatory filing regarding a legal proceeding ('소송등의판결ㆍ결정' - Judgment/Decision on Litigation). It details a court case involving the appointment of an inspector and the subsequent withdrawal of that application. As it pertains to legal matters and court proceedings, it falls under the 'Legal Proceedings Report' category.
2026-03-20 Korean
투자판단관련주요경영사항(임상시험계획승인신청) (SKI-O-703의 약물 제형 변경을 위한 임상 1상 IND 신청)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system (KIND) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically an application for clinical trial approval (IND). Since this is a formal regulatory disclosure of a material event that does not fit into specific categories like M&A, dividends, or financial reports, it is classified as a Regulatory Filing (RNS).
2026-03-19 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a '사업보고서' (Business Report) for the 28th fiscal year (2025), submitted to the Financial Services Commission and the Korea Exchange. It contains comprehensive company information, including business overview, management, capital structure, and financial data. In the Korean regulatory context, this is the standard Annual Report (10-K equivalent). FY 2025
2026-03-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.